About Index Trending news
Lists
Pricing
NovImmune

NovImmune

NovImmune

NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.
Founded
1998
Raised
$137.2M
Follow us
Alexa global traffic share